Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News TC BioPharm Holdings PLC (PK) TCBPY

Alternate Symbol(s):  TCBWF

Healthcare Biotechnology
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States. Its product pipeline comprises OmnImmune (TCB002), an allogeneic unmodified gamma-delta T cell therapy product which is in phase 2/3 clinical trial for the treatment of acute myeloid leukemia; and ImmuniStim, an... see more

Current News (PINL:TCBPY)

CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India

GlobeNewswire November 18, 2025

TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient

PR Newswire June 11, 2025

TCBP Announces Grant of European Patent for Targeting of Microbial, Oncological, and Viral Indications using Modified Gamma Delta T Cells

PR Newswire April 9, 2025

TCBP Announces Transition from Nasdaq to OTC Markets

PR Newswire March 21, 2025

TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead

PR Newswire March 18, 2025

TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company

PR Newswire March 5, 2025

TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum

PR Newswire February 20, 2025

TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial

PR Newswire February 13, 2025

TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial

PR Newswire February 10, 2025
View More News ››

Opinion & Analysis (PINL:TCBPY)

No current opinion is available.
View More Opinion ››

Bullboard Posts (PINL:TCBPY)

TCBP....Another one "bites the dust"

  TCBP Announces Transition from Nasdaq to OTC Markets   2025-03-21 07:45 ET - News Release   TCBP...
Iseneschal - March 21, 2025

TCBP.....looks like "The Stars" are aligning.....

Moving averages asetting up for a major move.....VWAP also JUst sayin ....On watch here
Iseneschal - February 26, 2025

TCBP....Big add down here at $2

Cheers !
Iseneschal - February 26, 2025

TCBP.....Have you seen the bottom??? $2.60 now

Nice little bounce this a.m from $2.03 Thank God it's Fryday Happy Valentines Day
Iseneschal - February 14, 2025

TCBP....trading at $2.21during PM open

C u sub $2
Iseneschal - February 14, 2025

TCBP.....How am I doing so far ???

Get ready for the New N.L.O.D start the drumroll $2.55
Iseneschal - February 13, 2025
View more Bullboard ››

Birchtech Corp.

Birchtech Corp.

Birchtech Corp., an environmental services and technology company, engages in developing and delivering solutions to the ...
View More »

Podcasts